| Tocilizumab for the treatment of severe coronavirus disease 2019 R Alattar, TBH Ibrahim, SH Shaar, S Abdalla, K Shukri, JN Daghfal, ... Journal of medical virology 92 (10), 2042-2049, 2020 | 295 | 2020 |
| A living WHO guideline on drugs to prevent covid-19 F Lamontagne, M Stegemann, A Agarwal, T Agoritsas, R Siemieniuk, ... bmj 372, 2021 | 138 | 2021 |
| Coronavirus disease 2019 disease severity in children infected with the omicron variant AA Butt, SR Dargham, S Loka, RM Shaik, H Chemaitelly, P Tang, ... Clinical Infectious Diseases 75 (1), e361-e367, 2022 | 137 | 2022 |
| Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 AS Omrani, SA Pathan, SA Thomas, TRE Harris, PV Coyle, CE Thomas, ... EClinicalMedicine 29, 2020 | 91 | 2020 |
| Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and … SJ Taj-Aldeen, A Kolecka, R Boesten, A Alolaqi, M Almaslamani, ... Infection 42, 393-404, 2014 | 80 | 2014 |
| Within-host diversity of SARS-CoV-2 in COVID-19 patients with variable disease severities HA Al Khatib, FM Benslimane, IE Elbashir, PV Coyle, MA Al Maslamani, ... Frontiers in cellular and infection microbiology 10, 575613, 2020 | 74 | 2020 |
| One year of SARS-CoV-2: genomic characterization of COVID-19 outbreak in Qatar FM Benslimane, HA Al Khatib, O Al-Jamal, D Albatesh, S Boughattas, ... Frontiers in cellular and infection microbiology 11, 768883, 2021 | 71 | 2021 |
| Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19 A Baiou, AA Elbuzidi, D Bakdach, A Zaqout, KM Alarbi, AA Bintaher, ... Journal of Hospital Infection 110, 165-171, 2021 | 69 | 2021 |
| Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study FY Khan, SS Elshafie, M Almaslamani, M Abu-Khattab, AH El Hiday, ... Travel medicine and infectious disease 8 (6), 377-387, 2010 | 66 | 2010 |
| NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression–The debate continues K Mushtaq, MU Khan, F Iqbal, DH Alsoub, HS Chaudhry, F Ata, P Iqbal, ... Journal of hepatology 74 (2), 482-484, 2021 | 65 | 2021 |
| COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar AA Butt, SR Dargham, P Tang, H Chemaitelly, MR Hasan, PV Coyle, ... Journal of global health 12, 2022 | 54 | 2022 |
| Imported malaria in Qatar: a one year hospital-based study in 2005 FY Khan, AK Lutof, MA Yassin, M Abu-Khattab, M Saleh, HY Rezeq, ... Travel medicine and infectious disease 7 (2), 111-117, 2009 | 54 | 2009 |
| The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study AS Omrani, MA Almaslamani, J Daghfal, RA Alattar, M Elgara, SH Shaar, ... BMC infectious diseases 20, 1-11, 2020 | 52 | 2020 |
| Epidemiology and clinical outcomes of viral central nervous system infections FB Abid, M Abukhattab, H Ghazouani, O Khalil, A Gohar, H Al Soub, ... International Journal of Infectious Diseases 73, 85-90, 2018 | 48 | 2018 |
| Phylogenetic diversity of human pathogenic Fusarium and emergence of uncommon virulent species H Salah, AMS Al-Hatmi, B Theelen, M Abukamar, S Hashim, ... Journal of Infection 71 (6), 658-666, 2015 | 48 | 2015 |
| Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 Carbapenemase in Qatar JM Rolain, L Loucif, M Al-Maslamani, E Elmagboul, N Al-Ansari, ... New Microbes and New Infections 11, 47-51, 2016 | 47 | 2016 |
| Mental Health, resilience, and religiosity in the elderly under COVID-19 quarantine in Qatar S Ouanes, R Kumar, ESI Doleh, M Smida, A Al-Kaabi, AM Al-Shahrani, ... Archives of Gerontology and Geriatrics 96, 104457, 2021 | 45 | 2021 |
| Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: a preliminary report AS Omrani, A Zaqout, A Baiou, J Daghfal, N Elkum, RA Alattar, D Bakdach, ... Journal of Medical Virology 93 (3), 1678-1686, 2021 | 39 | 2021 |
| Clinical practice guidelines for the management of invasive Candida infections in adults in the Middle East region: expert panel recommendations AF Alothman, T Al-Musawi, HM Al-Abdely, J Al Salman, M Almaslamani, ... Journal of infection and public health 7 (1), 6-19, 2014 | 39 | 2014 |
| Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications MAY Al-Nesf, HB Abdesselem, I Bensmail, S Ibrahim, WAH Saeed, ... Nature communications 13 (1), 946, 2022 | 37 | 2022 |
